| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/11/1998 | EP0822831A1 Vaccines containing a saponin and a sterol |
| 02/11/1998 | EP0822828A1 Isolated 55 to 75 kda protein which binds to prion protein |
| 02/11/1998 | EP0822817A1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 02/11/1998 | CN1173204A Immunogens for stimulating mucosal immunity |
| 02/11/1998 | CN1173203A Purified papillomavirus proteins |
| 02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
| 02/11/1998 | CN1173178A Imidazo £ 4, 5-c| quinoleine amines |
| 02/11/1998 | CN1173135A Use of bioassimilable boron compounds for the control of subviral pathogenic agents |
| 02/11/1998 | CN1173128A Polynucleotide compositions |
| 02/11/1998 | CN1172807A Neuraminic acid derivatives, their preparation and their medical use |
| 02/10/1998 | US5717083 Phosphoramidate and phosphorothiomidate oligomeric compounds |
| 02/10/1998 | US5717071 Culture product bactericide specific binding to lipopolysaccharide of outer membrane for treating bacterial infection |
| 02/10/1998 | US5716974 Heterobicyclic compounds with fungicidal activity |
| 02/10/1998 | US5716973 Anti-viral compounds |
| 02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
| 02/10/1998 | US5716955 Cytokine inhibitor |
| 02/10/1998 | US5716948 3-substituted carbacephems |
| 02/10/1998 | US5716939 Amide derivatives of 16-membered ring antibiotic macrolides |
| 02/10/1998 | US5716931 Administering lantibiotic by aerosol |
| 02/10/1998 | US5716793 Immunocomplexing |
| 02/10/1998 | US5716648 Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel diseases |
| 02/10/1998 | US5716620 Vaccines, diagnostic immunoassay |
| 02/10/1998 | US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments |
| 02/10/1998 | US5716406 Sterilizing by soaking the medical equipments in a solution containing antiinflammatory drugs prior to insertion or implantation in human or mammal |
| 02/10/1998 | CA2094914C Anthracycline analogues bearing latent alkylating substituents |
| 02/07/1998 | CA2210415A1 Xanthene and acridine derivatives and their use |
| 02/05/1998 | WO1998004732A1 SYNTHESIS OF β-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE |
| 02/05/1998 | WO1998004720A1 Method and reagents for genetic immunization |
| 02/05/1998 | WO1998004708A1 Anti-herpesviral agents and assays therefor |
| 02/05/1998 | WO1998004705A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 02/05/1998 | WO1998004703A1 THE NucA PROTEIN OF HAEMOPHILUS INFLUENZAE AND THE GENE ENCODING THAT PROTEIN |
| 02/05/1998 | WO1998004694A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004684A1 Recombinant swinepox virus |
| 02/05/1998 | WO1998004576A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | WO1998004574A1 Preparation of crystal form ii of clarithromycin |
| 02/05/1998 | WO1998004573A1 Crystal form i of clarithromycin |
| 02/05/1998 | WO1998004569A1 Nucleotide analogs |
| 02/05/1998 | WO1998004524A1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 02/05/1998 | WO1998004513A1 Water-miscible esters of monoglycerides having antimicrobial activity |
| 02/05/1998 | WO1998004290A2 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
| 02/05/1998 | WO1998004286A2 Assembly-deficient herpesvirus vaccine |
| 02/05/1998 | WO1998004284A1 Novel genes of kaposi's sarcoma associated herpesvirus |
| 02/05/1998 | WO1998004273A1 Method for treating gastrointestinal damage |
| 02/05/1998 | WO1998004157A1 Nutritional formulations containing water-miscible lipid derivatives as antimicrobial agents |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 02/05/1998 | DE19631037A1 Formulation of bactericide and terpene-containing plant extract |
| 02/05/1998 | CA2627035A1 Crystal form i of clarithromycin |
| 02/05/1998 | CA2262006A1 Method and reagents for genetic immunization |
| 02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2261164A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | CA2261071A1 Assembly-deficient herpesvirus vaccine |
| 02/05/1998 | CA2257421A1 Nutritional formulations containing water-miscible lipid derivatives as antimicrobial agents |
| 02/05/1998 | CA2257412A1 Water-miscible esters of monoglycerides having antimicrobial activity |
| 02/05/1998 | CA2253521A1 Synthesis of .beta.-lactam antibacterials using soluble side chain esters and enzyme acylase |
| 02/05/1998 | CA2232975A1 The nuca protein of haemophilus influenzae and the gene encoding that protein |
| 02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
| 02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
| 02/04/1998 | EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821948A2 Combination of active ingredients based on partial glycerides and dialkylsubstituted acetic acids efficient against bacteria, mycoses and viruses |
| 02/04/1998 | EP0821793A1 Methods of screening for therapeutic agents using novel apoptosis-modulating proteins |
| 02/04/1998 | EP0821736A1 Bacteriocins |
| 02/04/1998 | EP0821735A1 Helicobacter pylori cagi region |
| 02/04/1998 | EP0821698A1 Protective helicobacter antigens |
| 02/04/1998 | EP0821693A1 Novel human cytomegalovirus dna sequences |
| 02/04/1998 | EP0821692A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 02/04/1998 | EP0821690A1 Novel compounds and methods for therapy |
| 02/04/1998 | EP0821687A1 Preparation of clavulanate salts |
| 02/04/1998 | EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 02/04/1998 | EP0821665A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
| 02/04/1998 | EP0821586A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 02/04/1998 | EP0821584A1 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection |
| 02/04/1998 | EP0500791B1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 02/04/1998 | CN1172485A Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 02/04/1998 | CN1172484A Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
| 02/04/1998 | CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell |
| 02/04/1998 | CN1037268C Method for preparation of antipicornaviral phridazinamines |
| 02/04/1998 | CN1037267C Method for preparation of tri-substituted tetrahydrofuran derivative |
| 02/03/1998 | US5714608 1-substituted 1H-imidazo- 4,5-c!quinolin-4-amines |
| 02/03/1998 | US5714605 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 02/03/1998 | US5714593 Vaccines, medical diagnosis |
| 02/03/1998 | US5714516 Administering 2-hydroxymyristic acid or pentadecanoic or hexadecanoic acids 2-substituted with hydroxy or bromine as nontoxic agent against herpes virus |
| 02/03/1998 | US5714504 Alkaline salts of omeprazole; antiulcer agents; magnesium omeprazole or sodium omeprazole for example |
| 02/03/1998 | US5714490 4-(4-(4-(-((5-(2,4-dihalophenyl)--tetrahydro-5-(1h-1,2,4-triazol-1-ylmethyl)tetrahydrofur-3-yl)methoxy)phenyl)-2,4-dihydro-2-(mono- or dihydroxyalkyl)-3h-1,2,4-triazol-3-one; broad spectrum; water solubility; aspergillus; candida |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714462 Cd4 anti-retroviral activity potentiated by the addition of h2 histone or h2 histone-like protein; human immunodeficiency virus |
| 02/03/1998 | US5714353 Safe vectors for gene therapy |
| 02/03/1998 | US5714152 Herpes simplex virus VP16 vaccines |
| 01/29/1998 | WO1998003660A1 Feline polynucleotide vaccine formula |
| 01/29/1998 | WO1998003659A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | WO1998003658A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 01/29/1998 | WO1998003635A1 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same |
| 01/29/1998 | WO1998003572A1 Antiviral linear polymers |
| 01/29/1998 | WO1998003547A1 Antagonists of intestinotrophic glp-2 peptides |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003530A1 Novel erythromycin derivatives, method for preparing same and use thereof as drugs |
| 01/29/1998 | WO1998003516A1 Phosphinate based inhibitors of matrix metalloproteases |
| 01/29/1998 | WO1998003487A1 Compounds, compositions and methods for treating influenza |